Atlas Trials

Olanzapine Based Dexamethasone-sparing Regimen for Breast Cancer Patients With Metabolic-risk Factors

Clinical trial NCT07743827 · RECRUITING

Trial details

NCT number
NCT07743827
Sponsor
Alexandria University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
OlanzapineBreast CancerDexamethasone
Start date
2026-05-10
Primary completion
2027-09-29
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.